Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Duolac 7S Administration on Improving Symptom in Irritable Bowel Syndrome

NCT01088971 is registered in ClinicalTrials.gov with Cell Biotech Co., Ltd. as lead sponsor.

NCT NCT01088971
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01088971 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Duolac 7S Administration on Improving Symptom in Irritable Bowel Syndrome
Lead sponsor
Cell Biotech Co., Ltd.
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2009
Completion date
July 31, 2011
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

irritable bowel syndrome